Advertisement
ADPT or ISRG or NTRA
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ADPT’s FA Score shows that 0 FA rating(s) are green whileISRG’s FA Score has 0 green FA rating(s), and NTRA’s FA Score reflects 1 green FA rating(s).
- ADPT’s FA Score: 0 green, 5 red.
- ISRG’s FA Score: 0 green, 5 red.
- NTRA’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ADPT’s TA Score shows that 3 TA indicator(s) are bullish while ISRG’s TA Score has 4 bullish TA indicator(s), and NTRA’s TA Score reflects 3 bullish TA indicator(s).
- ADPT’s TA Score: 3 bullish, 5 bearish.
- ISRG’s TA Score: 4 bullish, 4 bearish.
- NTRA’s TA Score: 3 bullish, 5 bearish.
Price Growth
ADPT (@Medical Specialties) experienced а +3.15% price change this week, while ISRG (@Pharmaceuticals: Other) price change was -4.29% , and NTRA (@Medical Specialties) price fluctuated +8.03% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +5.38%. For the same industry, the average monthly price growth was +16.48%, and the average quarterly price growth was +29.67%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.32%. For the same industry, the average monthly price growth was +12.36%, and the average quarterly price growth was +5.53%.
Reported Earning Dates
ADPT is expected to report earnings on Nov 05, 2026.
ISRG is expected to report earnings on Oct 20, 2026.
NTRA is expected to report earnings on Nov 11, 2026.
Industries' Descriptions
@Medical Specialties (+5.38% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Pharmaceuticals: Other (+2.32% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| ADPT | ISRG | NTRA | |
| Capitalization | 4.19B | 132B | 48.5B |
| EBITDA | -20.94M | 4.25B | -227.7M |
| Gain YTD | 61.638 | -34.040 | 46.977 |
| P/E Ratio | N/A | 42.84 | N/A |
| Revenue | 295M | 11B | 2.5B |
| Total Cash | 218M | 5.22B | 1.09B |
| Total Debt | 77.6M | 87M | 240M |
ADPT | ISRG | NTRA | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 82 | 35 | 70 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 47 Fair valued | 73 Overvalued | 54 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 88 | 19 | |
SMR RATING 1..100 | 97 | 51 | 95 | |
PRICE GROWTH RATING 1..100 | 35 | 61 | 36 | |
P/E GROWTH RATING 1..100 | 100 | 86 | 100 | |
SEASONALITY SCORE 1..100 | 35 | 75 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ADPT's Valuation (47) in the Hospital Or Nursing Management industry is in the same range as NTRA (54) in the Biotechnology industry, and is in the same range as ISRG (73) in the Medical Specialties industry. This means that ADPT's stock grew similarly to NTRA’s and similarly to ISRG’s over the last 12 months.
NTRA's Profit vs Risk Rating (19) in the Biotechnology industry is significantly better than the same rating for ISRG (88) in the Medical Specialties industry, and is significantly better than the same rating for ADPT (100) in the Hospital Or Nursing Management industry. This means that NTRA's stock grew significantly faster than ISRG’s and significantly faster than ADPT’s over the last 12 months.
ISRG's SMR Rating (51) in the Medical Specialties industry is somewhat better than the same rating for NTRA (95) in the Biotechnology industry, and is somewhat better than the same rating for ADPT (97) in the Hospital Or Nursing Management industry. This means that ISRG's stock grew somewhat faster than NTRA’s and somewhat faster than ADPT’s over the last 12 months.
ADPT's Price Growth Rating (35) in the Hospital Or Nursing Management industry is in the same range as NTRA (36) in the Biotechnology industry, and is in the same range as ISRG (61) in the Medical Specialties industry. This means that ADPT's stock grew similarly to NTRA’s and similarly to ISRG’s over the last 12 months.
ISRG's P/E Growth Rating (86) in the Medical Specialties industry is in the same range as ADPT (100) in the Hospital Or Nursing Management industry, and is in the same range as NTRA (100) in the Biotechnology industry. This means that ISRG's stock grew similarly to ADPT’s and similarly to NTRA’s over the last 12 months.
| ADPT | ISRG | NTRA | |
|---|---|---|---|
| RSI ODDS (%) | 2 days ago 80% | 2 days ago 43% | 2 days ago 58% |
| Stochastic ODDS (%) | 2 days ago 87% | 2 days ago 63% | 2 days ago 66% |
| Momentum ODDS (%) | 2 days ago 84% | 2 days ago 67% | 2 days ago 84% |
| MACD ODDS (%) | 2 days ago 83% | 2 days ago 72% | 2 days ago 88% |
| TrendWeek ODDS (%) | 2 days ago 83% | 2 days ago 64% | 2 days ago 81% |
| TrendMonth ODDS (%) | 2 days ago 84% | 2 days ago 64% | 2 days ago 82% |
| Advances ODDS (%) | 21 days ago 83% | 7 days ago 65% | 22 days ago 80% |
| Declines ODDS (%) | 13 days ago 85% | 27 days ago 61% | 12 days ago 77% |
| BollingerBands ODDS (%) | 2 days ago 82% | N/A | 2 days ago 76% |
| Aroon ODDS (%) | 2 days ago 87% | N/A | 2 days ago 81% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EOSU | 6.73 | 0.28 | +4.34% |
| T-REX 2X Long Eose Daily Target ETF | |||
| SGOL | 44.43 | 0.14 | +0.32% |
| abrdn Physical Gold Shares ETF | |||
| CTEF | 88.54 | 0.28 | +0.31% |
| Castellan Targeted Equity ETF | |||
| XHE | 96.03 | 0.08 | +0.08% |
| Stt Strt® SPDR® S&P®HlthCrEqpmntETF | |||
| MYCF | 25.06 | N/A | +0.02% |
| State Street® My2026 Corporate Bond ETF | |||
ADPT and
Correlation & Price change
A.I.dvisor indicates that over the last year, ADPT has been loosely correlated with AXON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ADPT jumps, then AXON could also see price increases.
| Ticker / NAME | Correlation To ADPT | 1D Price Change % | ||
|---|---|---|---|---|
| ADPT | 100% | +2.74% | ||
| AXON - ADPT | 56% Loosely correlated | +2.62% | ||
| PSNL - ADPT | 56% Loosely correlated | +1.11% | ||
| VCYT - ADPT | 53% Loosely correlated | +6.20% | ||
| ARRY - ADPT | 50% Loosely correlated | -0.44% | ||
| NTRA - ADPT | 49% Loosely correlated | +2.74% | ||
More | ||||